Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $2.573B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 12,886,743 | $1.979B | 76.9% | $16.43 | +903.8% | COM | 60770K107 |
| — | Omega Therapeutics Inc | 29,225,579 | $176M | 6.8% | $17.39 | — | COM | 68217N105 |
| — | Seres Therapeutics Inc | 23,117,045 | $131M | 5.1% | $7.75 | — | COM | 81750R102 |
| SANA | Sana Biotechnology Inc | 34,239,018 | $112M | 4.4% | $32.56 | -87.7% | COM | 799566104 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $78.58M | 3.1% | $19.16 | -65.8% | COM | 344174107 |
| DNLI | Denali Therapeutics Inc | 2,619,968 | $60.36M | 2.3% | $17.97 | +53.1% | COM | 24823R105 |
| — | Axcella Health Inc | 29,251,545 | $14.04M | 0.5% | $4.17 | — | COM | 05454B105 |
| — | Sigilon Therapeutics Inc | 10,370,369 | $9.645M | 0.4% | $48.03 | — | COM | 82657L107 |
| — | Evelo Biosciences Inc | 50,427,328 | $9.112M | 0.4% | $5.89 | — | COM | 299734103 |
| SYRS | Syros Pharmaceuticals Inc | 993,848 | $2.654M | 0.1% | $8.12 | -52.3% | COM | 87184Q206 |
| — | Codiak Biosciences Inc | 3,540,636 | $618K | 0.0% | $23.99 | — | COM | 192010106 |